Sensitivity of the Epstein–Barr Virus Transformed Human Lymphoid Cell Lines to Interferon

References

1. Adams A. 1973; Concentration of Epstein–Barr virus from cell culture fluids with polyethylene glycol. Journal of General Virology 20:391–394
   [Google Scholar]
2. Adams A., Klein G. 1973; Superinfection with Epstein–Barr virus of human lymphoid cell lines of different origins. Nature New Biology 242:234–236
   [Google Scholar]
3. Adams A., Lindahl T. 1975; Epstein–Barr virus genomes with properties of circular DNA molecules in carrier cells. Proceedings of the National Academy of Sciences of the United States of America (in the press)
   [Google Scholar]
4. Adams A., Lidin B., Strander H., Cantell K. 1975; Spontaneous interferon production and Epstein–Barr virus antigen expression in human lymphoid cell lines. Journal of General Virology 28:219–223
   [Google Scholar]
5. Cantell K., Pyhala L. 1973; Circulating interferon in rabbits after administration of human interferon by different routes. Journal of General Virology 20:97–104
   [Google Scholar]
6. Cantell K., Hirvonen S., Mogensen K. E., Pyhälä L. 1974; Human leukocyte interferon: production, purification, stability, and animal experiments. In The production and use of interferon for the treatment and prevention of human virus infections pp 35–38 In Vitro, Monograph No. 3
   [Google Scholar]
7. Clarkson B., Striss A., De Harven E. 1967; Continuous culture of seven new lines (SKL-i to 7) from patients with acute leukemia. Cancer 20:920–947
   [Google Scholar]
8. Durr F. E., Monroe J. H., Schmitter R., Traul K. A., Hirshaut Y. 1970; Studies on the infectivity and cytopathology of Epstein–Barr virus in human lymphoblastoid cells. International Journal of Cancer 6:436–449
   [Google Scholar]
9. Gerber P. 1972; Activation of EBV by 5-bromodeoxyuridine in ‘virus-free’ human cells. Proceedings of the National Academy of Sciences of the United States of America 69:83–85
   [Google Scholar]
10. Gergely L., Klein G., Ernberg I. 1971; The action of DNA antagonists on Epstein–Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines. International Journal of Cancer 7:293–302
    [Google Scholar]
11. Gresser I. 1972; Antitumor effects of interferon. Advances in Cancer Research 16:97–140
    [Google Scholar]
12. Gresser I. 1974; Antitumor effects of interferon. Conference on ‘Modulation of host immune resistance in the prevention or treatment of induced neoplasias Bethesda; Maryland:9–11 December (in the press)
    [Google Scholar]
13. Gresser I., Falcoff R., Fontaine-Brouty-Boye D., Zajdela F., Coppey J., Falcoff E. 1967; Interferon and murine leukemia. IV. Further studies on the efficacy of interferon preparations administered after inoculation of Friend virus. Proceedings of the Society for Experimental Biology and Medicine 126:791–797
    [Google Scholar]
14. Hinuma Y., Grace J. T. 1967; Cloning of immunoglobulin-producing human leukemia and lymphoma cells in long term cultures. Proceedings of the Society for Experimental Biology, New York 124:107–111
    [Google Scholar]
15. Ikawata S., Grace J. T. 1964; Cultivation in vitro of myeloblasts from human leukemia. New York State Medical Journal 64:2279–2282
    [Google Scholar]
16. International Symposium on Standardization of Interferon and Interferon Inducers, London 1969 Symp. Ser. Immunol. Standard 14326 Basel and New York: Karger;
17. Junge V., Hoekstra J., Deinhardt F. 1971; Stimulation of peripheral lymphocytes by allogeneic and autochthonous mononucleosis lymphocyte cell lines. Journal of Immunology 106:1306–1315
    [Google Scholar]
18. Klein E., Klein G., Nadkarni J. S., Nadkarni J. J., Wigzell H., Clifford P. 1967; Surface IgM kappa specificity on a Burkitt lymphoma cell in vitro and in derived culture lines. Cancer Research 28:1300–1310
    [Google Scholar]
19. Klein G. 1973; The Epstein–Barr virus (EBV). In The Herpesviruses pp 521–555 Edited by Kaplan A. New York: Academic Press;
    [Google Scholar]
20. Klein G., Dombos L. 1973; Relationship between the sensitivity of EBV-carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome. International Journal of Cancer 11:327–337
    [Google Scholar]
21. Klein G., Dombos L., Gothoskar B. 1972; Sensitivity of Epstein–Barr virus (EBV) producer and nonproducer human lymphoblastoid cell lines to superinfection with EB-virus. International Journal of Cancer 10:44–57
    [Google Scholar]
22. Lindahl T., Klein G., Reedman B. M., Johansson B., Singh S. 1974; Relationship between Epstein–Barr virus (EBV) DNA and the EBV determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies. International Journal of Cancer 13:764–772
    [Google Scholar]
23. Lockart R. Z. 1973; Interference and interferon with respect to herpesviruses. In The Herpesviruses pp 262–269 Edited by Kaplan A. New York: Academic Press;
    [Google Scholar]
24. Miller G. 1971; Human lymphoblastoid cell lines and Epstein–Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man. Yale Journal of Biology and Medicine 43:358–384
    [Google Scholar]
25. Miller G. 1974; The oncogenicity of Epstein–Barr virus. Journal of Infectious Diseases 130:187–205
    [Google Scholar]
26. Mogensen K. E., Cantell K. 1973; Stability of human leukocyte interferon towards heat. Acta Pathologica Microbiologica Scandinavica 81:382–383
    [Google Scholar]
27. Mogensen K. E., Cantell K. 1974a; Human leukocyte interferon: a role for disulphide bonds. Journal of General Virology 22:95–103
    [Google Scholar]
28. Mogensen K. E., Cantell K. 1974b; Loss of specific antigenicity on carboxymethylation of mercapto-ethanol-reduced interferon of human leukocyte origin. Intervirology 2:52–55
    [Google Scholar]
29. Nonoyama M., Pagano J. S. 1973; Homology between Epstein–Barr virus DNA and viral DNA from Burkitt’s lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature, London 242:44–47
    [Google Scholar]
30. Oxman M. N. 1973; Interferon, tumors and tumor viruses. In Interferons and Interferon Inducers pp 391–480 Edited by Finter N. B. Amsterdam: North Holland Publishing Company;
    [Google Scholar]
31. Pulvertaft R. J. V. 1965; A study of malignant tumours in Nigeria by short term tissue culture. Journal of Clinical Pathology 18:261–273
    [Google Scholar]
32. Reedman B. M., Klein G. 1973; Cellular localization of an Epstein–Barr virus (EBV)-associated complement fixing antigen in producer and non-producer lymphoblastoid cell lines. International Journal of Cancer 11:499–520
    [Google Scholar]
33. Strander H., Cantell K. 1966; Production of interferon by human leukocytes in vitro. Annales Medicinae Experimentalis et Biologiae Fenniae 44:265–273
    [Google Scholar]
34. Sugawara K., Mizuno F., Osato T. 1972; Epstein–Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines. Nature New Biology 239:242–243
    [Google Scholar]
35. Yata J., Klein G. 1969; Some factors affecting membrane immunofluorescence reactivity of Burkitt lymphoma tissue culture cell lines. International Journal of Cancer 4:767–775
    [Google Scholar]
36. Zur Hausen H., Diehl V., Wolf H., Schulte-Holthausen H., Schneider U. 1972; Occurrence of Epstein–Barr virus genomes in human lymphoblastoid cell lines. Nature New Biology 237189–190
    [Google Scholar]